Beta-blockers curb death risk in high-risk STEMI patients

02/17/2013 | PhysiciansBriefing.com

A study in The American Journal of Cardiology found beta-blocker treatment may help cut long-term mortality in high-risk ST-segment elevation myocardial infarction patients. However, the therapy did not appear to benefit lower-risk patients, researchers said.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA